先瑞达医疗-B(06669)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06669 先瑞达医疗-B

交易中 06-06 11:24:36

15.920

+0.220

+1.40%

最高16.000	最低15.520	成交量724.60万
今开15.520	昨收15.700	日振幅3.06%
总市值49.89亿	流通市值49.89亿	总股本3.13亿
成交额1.14亿	换手率2.31%	流通股本3.13亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06669","market":"HK","secType":"STK","nameCN":"先瑞达医疗-B","latestPrice":15.92,"timestamp":1686021706213,"preClose":15.7,"halted":0,"volume":7246000,"delay":0,"floatShares":313389171,"shares":313389171,"eps":0.2578859,"marketStatus":"交易中","marketStatusCode":2,"change":0.22,"latestTime":"06-06 11:24:36","open":15.52,"high":16,"low":15.52,"amount":113770420,"amplitude":0.030573,"askPrice":15.96,"askSize":3000,"bidPrice":15.92,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":0.2533584706694056,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1686024000000},"adr":0,"listingDate":1629734400000,"adjPreClose":15.7,"volumeRatio":72.214013,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06669","defaultTab":"news","newsList":[{"id":"2339254232","title":"先瑞达医疗-B盘中异动 大幅下跌5.06%报15.001港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2339254232","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2339254232?lang=zh_CN&edition=full","pubTime":"2023-05-31 14:29","pubTimestamp":1685514596,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305311429568066d56e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305311429568066d56e&s=b","is_publish_highlight":false},{"id":"2339541413","title":"先瑞达医疗-B盘中异动 下午盘股价大跌5.00%报15.941港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2339541413","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2339541413?lang=zh_CN&edition=full","pubTime":"2023-05-29 14:40","pubTimestamp":1685342408,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305291440088066cbdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305291440088066cbdd&s=b","is_publish_highlight":false},{"id":"2334877463","title":"“摘B”再添新军，港股生物科技股板块热度重燃？","url":"https://stock-news.laohu8.com/highlight/detail?id=2334877463","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2334877463?lang=zh_CN&edition=full","pubTime":"2023-05-11 19:56","pubTimestamp":1683806211,"startTime":"0","endTime":"0","summary":"又有两家未盈利的生物科技公司宣布“摘B”。2023年5月9日，3D MEDICINES-B（01244.HK）（简称“思路迪”）及诺诚健华-B（09969.HK）先后发布公告称，宣布已获得香港联交所批准，公司股份简称即将删除“B”标记。其中，诺诚健华-B表示将自5月12日起，股份简称将不再标记“B”，而思路迪则表示，“摘B”生效日期将适时进一步公告。","market":"hk","thumbnail":"https://images.finet.hk/photoLib/title/202305_1/c3a9e12e-7ded-4136-b6c8-2e31cea175bd.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202305_1/c3a9e12e-7ded-4136-b6c8-2e31cea175bd.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/645cd80353243c2a2d950421","is_publish_highlight":false},{"id":"2329221017","title":"先瑞达Vericor-14®微导管获NMPA批准上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2329221017","media":"发布易","top":-1,"share":"https://www.laohu8.com/m/news/2329221017?lang=zh_CN&edition=full","pubTime":"2023-04-21 10:19","pubTimestamp":1682043566,"startTime":"0","endTime":"0","summary":"2023年4月19日，先瑞达Vericor-14微导管取得NMPA注册批准，该产品适用于冠状动脉及外周血管的经皮介入手术中，针对狭窄血管病变部位，引导导丝，并为交换导丝和输送生理盐水或诊断造影剂提供通道。Vericor-14微导管拥有新型显影性复合聚酯材料尖端，相比传统金属显影环，在等同显影性下大幅降低了损伤血管的风险。Vericor-14微导管是2022年12月以来，先瑞达在心脏科获批的第三个产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=d1PnFDPT3o8%3D","is_publish_highlight":false},{"id":"2329746195","title":"公告精选(港股)︱中国移动一季度净利润281亿元同比增长9.5%；融创中国境外债务重组方案已获超75％债权人支持","url":"https://stock-news.laohu8.com/highlight/detail?id=2329746195","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2329746195?lang=zh_CN&edition=full","pubTime":"2023-04-21 00:38","pubTimestamp":1682008739,"startTime":"0","endTime":"0","summary":"中国电信(00728.HK)一季度归母净利79.84亿元 同比增长10.5%；深圳控股(00604.HK)3月份合同销售额15.04亿元 同比上升590.0%","market":"us","thumbnail":"https://img7.gelonghui.com/column/2/108.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/108.png"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/596133","is_publish_highlight":false},{"id":"2328710342","title":"先瑞达医疗-B(06669)：国家药监局批准微导管VERICOR-14®","url":"https://stock-news.laohu8.com/highlight/detail?id=2328710342","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2328710342?lang=zh_CN&edition=full","pubTime":"2023-04-20 22:07","pubTimestamp":1681999667,"startTime":"0","endTime":"0","summary":"智通财经APP讯，先瑞达医疗-B(06669)发布公告，于2023年4月19日，公司收到中国国家药品监督管理局对微导管Vericor-14®的注册批准。该产品适用于冠脉及外周血管经皮介入手术中，针对狭窄血管病变部位，引导导丝，并为交换导丝和输送生理盐水或诊断造影剂提供通道。公司将在中国市场适时开展市场营销活动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/914693.html","is_publish_highlight":false},{"id":"2328731114","title":"公告精选(港股)︱新东方第三季净利同比上升166.7%至8160万美元；联邦制药旗下司美格鲁肽生物类似药获批减肥临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2328731114","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2328731114?lang=zh_CN&edition=full","pubTime":"2023-04-20 01:13","pubTimestamp":1681924413,"startTime":"0","endTime":"0","summary":"科济药业-B(02171.HK)：CT041获批用于CLDN18.2表达阳性的胰腺癌术后辅助治疗；瑞科生物-B(02179.HK)发行内资股获中国证监会批复","market":"hk","thumbnail":"https://img7.gelonghui.com/column/2/108.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/108.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/595700","is_publish_highlight":false},{"id":"2328099502","title":"先瑞达医疗-B(06669.HK)：国家药监局批准ACOART AVENS","url":"https://stock-news.laohu8.com/highlight/detail?id=2328099502","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2328099502?lang=zh_CN&edition=full","pubTime":"2023-04-19 16:59","pubTimestamp":1681894777,"startTime":"0","endTime":"0","summary":"格隆汇4月19日丨先瑞达医疗-B(06669.HK)发布公告，2023年4月18日，公司收到中国国家药品监督管理局对紫杉醇涂层动静脉瘘高压球囊扩张导管ACOART AVENS的注册批准，该产品用于血液透析患者自体动静脉瘘狭窄PTA术。公司对产品设计进行了改进，优化了产品涂层，应用了新型材料，从而进一步提升了治疗效果和操作便捷度。公司将在中国市场适时开展市场营销活动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023041916594384271f60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023041916594384271f60&s=b","is_publish_highlight":false},{"id":"2325371105","title":"先瑞达医疗(06669.HK)：中国国家药监局批准ACOSTREAM二代","url":"https://stock-news.laohu8.com/highlight/detail?id=2325371105","media":"格隆汇APP","top":-1,"share":"https://www.laohu8.com/m/news/2325371105?lang=zh_CN&edition=full","pubTime":"2023-04-06 18:33","pubTimestamp":1680777183,"startTime":"0","endTime":"0","summary":"格隆汇4月6日丨先瑞达医疗(06669.HK)发布公告，于2023年4月4日，公司收到中国国家药品监督管理局对AcoStream二代的注册批准。AcoStream二代是用于去除外周血管系统中血栓的产品。公司改进了产品的设计从而进一步提升了治疗效果和操作便捷度。公司将在中国市场适时开展市场营销活动。\n\n炒股开户享福利，送投顾服务60天体验权，一对一指导服务！\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-04-06/doc-imypmuta8955863.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-04-06/doc-imypmuta8955863.shtml","is_publish_highlight":false},{"id":"2325616371","title":"先瑞达医疗-B(06669)：AcoStream™二代获国家药监局批准注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2325616371","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2325616371?lang=zh_CN&edition=full","pubTime":"2023-04-06 18:24","pubTimestamp":1680776682,"startTime":"0","endTime":"0","summary":"智通财经APP讯，先瑞达医疗-B(06669)发布公告，于2023年4月4日，公司收到中国国家药品监督管理局对AcoStream™二代的注册批准。AcoStream™二代是用于去除外周血管系统中血栓的产品。集团改进了产品的设计从而进一步提升了治疗效果和操作便捷度。公司将在中国市场适时开展市场营销活动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/907157.html","is_publish_highlight":false},{"id":"2324019418","title":"先瑞达医疗(06669.HK)：穿越行业周期，彰显“黑马”特质","url":"https://stock-news.laohu8.com/highlight/detail?id=2324019418","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2324019418?lang=zh_CN&edition=full","pubTime":"2023-04-04 21:38","pubTimestamp":1680615493,"startTime":"0","endTime":"0","summary":"先瑞达公司丰富的产品线、坚实的技术创新能力和高水平的管理团队等优秀基因或将是市场不容忽视的沧海遗珠。","market":"hk","thumbnail":"https://img7.gelonghui.com/column/7.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/7.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/591496","is_publish_highlight":false},{"id":"2322405417","title":"先瑞达医疗-B(06669)收到泰国食品及药品管理局对Vericor®的注册批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2322405417","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2322405417?lang=zh_CN&edition=full","pubTime":"2023-03-28 06:23","pubTimestamp":1679955821,"startTime":"0","endTime":"0","summary":"先瑞达医疗-B(06669)发布公告，于2023年3月23日，集团收到泰国食品及药...","market":"sh","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_32.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_32.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/899928.html","is_publish_highlight":false},{"id":"2321130636","title":"先瑞达医疗-B发布年度业绩 经调整溢利净额8566.4万元同比增长159.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2321130636","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2321130636?lang=zh_CN&edition=full","pubTime":"2023-03-24 09:13","pubTimestamp":1679620387,"startTime":"0","endTime":"0","summary":"先瑞达医疗-B（06669）发布截至2022年12月31日止年度业绩，收益3.96亿元（人民币，下同），同比增长30.2%；年内溢利7014.2万元，同比扭亏为盈；经调整溢利净额8566.4万元，同比增长159.3%；每股盈利0.23元。\n\n炒股开户享福利，送投顾服务60天体验权，一对一指导服务！\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-03-24/doc-imymxpap9810314.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-03-24/doc-imymxpap9810314.shtml","is_publish_highlight":false},{"id":"2321904476","title":"先瑞达发布2022年业绩报告：全年营收3.96亿元同比增长30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2321904476","media":"金融界网站","top":-1,"share":"https://www.laohu8.com/m/news/2321904476?lang=zh_CN&edition=full","pubTime":"2023-03-23 21:57","pubTimestamp":1679579852,"startTime":"0","endTime":"0","summary":"金融界3月23日消息，先瑞达发布了截至2022年12月31日的年度业绩报告。2022年全年，先瑞达营业总收入达3.96亿元人民币，较2021年同比增长30%；毛利润3.36亿元人民币，较2021年同比增长26%；毛利率达85%，净利润为7014万元人民币。　　从业绩数据中，其静脉介入及通路类产品的收入收入达8603万元人民币，占总营收从去年同期的8%提升至21.8%。　　毛利及毛利率：2022年毛利为3.364亿元，较2021年的2.659亿元增长26.5%；毛利率由2021年的87.5%下降至85%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hk.jrj.com.cn/2023/03/23215737423977.shtml","is_publish_highlight":false},{"id":"2321490626","title":"先瑞达医疗-B(06669)发布年度业绩，经调整溢利净额8566.4万元，同比增长159.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2321490626","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2321490626?lang=zh_CN&edition=full","pubTime":"2023-03-23 21:07","pubTimestamp":1679576851,"startTime":"0","endTime":"0","summary":"智通财经APP讯，先瑞达医疗-B 发布截至2022年12月31日止年度业绩，收益3.96亿元，同比增长30.2%;年内溢利7014.2万元，同比扭亏为盈;经调整溢利净额8566.4万元，同比增长159.3%;每股盈利0.23元。于2022年，公司在研发范畴方面取得重大进展。截至2022年12月31日，公司已新提交申请18项专利，其中4项申请获批。DCB产品的销售收益于截至2022年12月31日止年度占总收益的约77.7%，而于截至2021年12月31日止年度占约98.5%，乃由于公司的商业化产品众多所致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/897519.html","is_publish_highlight":false},{"id":"2321691806","title":"先瑞达医疗-B盘中异动 快速拉升5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2321691806","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2321691806?lang=zh_CN&edition=full","pubTime":"2023-03-21 10:33","pubTimestamp":1679365996,"startTime":"0","endTime":"0","summary":"2023年03月21日早盘10时33分，先瑞达医疗-B股票出现异动，股价快速拉升5.23%。截至发稿，该股报13.681港元/股，成交量3.6万股，换手率0.01%，振幅4.46%。先瑞达医疗-B股票所在的医疗保健设备行业中，整体涨幅为0.30%。其相关个股中，微创机器人-B、先瑞达医疗-B、诺辉健康涨幅较大，振幅较大的相关个股有HKE HOLDINGS、微创机器人-B、高视医疗，振幅分别为14.17%、6.99%、6.96%。先瑞达医疗-B公司简介：先瑞达医疗科技控股有限公司是一家介入医疗器械中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230321103316846dfae4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230321103316846dfae4&s=b","is_publish_highlight":false},{"id":"2319691026","title":"先瑞达医疗－Ｂ(06669)股价下跌5.124%，现价港币$12.22","url":"https://stock-news.laohu8.com/highlight/detail?id=2319691026","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2319691026?lang=zh_CN&edition=full","pubTime":"2023-03-14 13:05","pubTimestamp":1678770300,"startTime":"0","endTime":"0","summary":"[下跌股]先瑞达医疗－Ｂ(06669) 股价在下午01:05比前收市价下跌5.124%，现股价为港币$12.22。至目前为止，今日最高价为$12.88，而最低价为$12.22。总成交量为3.934万股，总成交金额为港币$49.247万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2303143567/aamm-all-category","is_publish_highlight":false},{"id":"2319043888","title":"先瑞达医疗－Ｂ(06669.HK)斥2.6亿人币租赁北京物业作医疗器械研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2319043888","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2319043888?lang=zh_CN&edition=full","pubTime":"2023-03-14 08:44","pubTimestamp":1678754640,"startTime":"0","endTime":"0","summary":"先瑞达医疗－Ｂ(06669.HK) 公布，其全资附属北京先瑞达与一名独立第三方业主亦庄城市更新，就租赁北京经济技术开发区核心区0106街区22M2地块订立租赁协议，租期自2023年3月13日至2033年3月12日止为期十年，以供集团进行医疗器械研发、测试及制造，总租金共2.57亿元人民币。(jl/s)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220216160327428_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220216160327428_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1251310/latest-news/HK6","is_publish_highlight":false},{"id":"2319198017","title":"先瑞达医疗-B(06669)附属拟租赁北京物业以供集团进行医疗器械研发、测试及制造","url":"https://stock-news.laohu8.com/highlight/detail?id=2319198017","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2319198017?lang=zh_CN&edition=full","pubTime":"2023-03-14 07:51","pubTimestamp":1678751509,"startTime":"0","endTime":"0","summary":"先瑞达医疗-B(06669)发布公告，于2023年3月13日，公司全资附属公司北京...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_5.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_5.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/891249.html","is_publish_highlight":false},{"id":"2319010507","title":"先瑞达医疗-B(06669.HK)附属北京先瑞达就租赁物业订立租赁协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2319010507","media":"金融界网站","top":-1,"share":"https://www.laohu8.com/m/news/2319010507?lang=zh_CN&edition=full","pubTime":"2023-03-14 07:33","pubTimestamp":1678750434,"startTime":"0","endTime":"0","summary":"格隆汇3月14日丨先瑞达医疗-B(06669.HK)发布公告，2023年3月13日，公司全资附属公司北京先瑞达(作为租户)与一名独立第三方亦庄城市更新(作为业主)就租赁物业订立租赁协议，租期自2023年3月13日至2033年3月12日止(包括首尾两天)为期十年，以供集团进行医疗器械研发、测试及制造。该物业为北京市北京经济技术开发区核心区0106街区22M2地块，面积约为23,635平方米。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hk.jrj.com.cn/2023/03/14073337398122.shtml","is_publish_highlight":false}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0163},{"period":"1month","weight":0.0813},{"period":"3month","weight":0.1295},{"period":"6month","weight":0.1198},{"period":"1year","weight":1.4608},{"period":"ytd","weight":-0.0861}],"websiteUrl":null,"compareEarnings":[{"period":"1week","weight":0.03},{"period":"1month","weight":-0.0469},{"period":"3month","weight":-0.0694},{"period":"6month","weight":0.0156},{"period":"1year","weight":-0.0936},{"period":"ytd","weight":-0.034}],"name":"先瑞达医疗-B","description":"先瑞达医疗科技控股有限公司是一家介入医疗器械中国公司。该公司专注于血管疾病介入治疗，涉及药物涂层球囊(DCB)、外周球囊扩张导管(PTA)等。该公司针对五大治疗领域建立产品组合，包括血管外科、心脏科、肾脏科、神经科及男科。该公司的业务遍及中国以及亚洲、欧洲等国家及地区。","exchange":"SEHK","nameEN":"ACOTEC-B","compareStock":{"symbol":"HSI","name":"恒生指数"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.13.0","shortVersion":"4.13.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"先瑞达医疗-B(06669)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供先瑞达医疗-B(06669)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"先瑞达医疗-B,06669,先瑞达医疗-B股票,先瑞达医疗-B股票老虎,先瑞达医疗-B股票老虎国际,先瑞达医疗-B行情,先瑞达医疗-B股票行情,先瑞达医疗-B股价,先瑞达医疗-B股市,先瑞达医疗-B股票价格,先瑞达医疗-B股票交易,先瑞达医疗-B股票购买,先瑞达医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"先瑞达医疗-B(06669)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供先瑞达医疗-B(06669)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}